Managers / Q4 2019 · view latest →
AlphaMark Advisors, LLC
CIK 0001348183 · 810 WRIGHT'S SUMMIT PKWY, SUITE 100, FT. WRIGHT, KY, 41011 · 859-957-1803
Summary
Alphamark Advisors, LLC reported $239M in U.S.-listed holdings across 514 positions for Q4 2019.
Its largest position, Alphamark Actively Man, represents 9.0% of the portfolio.
Compared with Q3 2019, the fund opened 38 new positions and exited 34.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 51.7% · $124M
- ETP · 26.5% · $63M
- Other · 18.4% · $44M
- ADR · 1.6% · $4M
- REIT · 1.0% · $2M
- Other · 0.8% · $2M
Quarter-over-Quarter Changes full breakdown →
vs Q3 2019 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| ALXNAlexion Pharmaceutical | NEW | +29.5K | 29.5K | +$3M | $3M |
| VTVVanguard Value | NEW | +7.4K | 7.4K | +$890,000 | $890,000 |
| Bristol-Myers Squibb R | NEW | +239.2K | 239.2K | +$720,000 | $720,000 |
| TFCTruist Finl Corp | NEW | +4.7K | 4.7K | +$265,000 | $265,000 |
| Metlife Pfd | NEW | +4.0K | 4.0K | +$99,000 | $99,000 |
| Invesco Bulletshares 2 | NEW | +3.6K | 3.6K | +$77,000 | $77,000 |
| PGXInvesco Preferred ETF | NEW | +4.0K | 4.0K | +$60,000 | $60,000 |
| BCEBCE | NEW | +850 | 850 | +$39,000 | $39,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2019
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q4 2024 | $231M | 642 | Jan 21, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $290M | 707 | Oct 16, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $288M | 773 | Jul 17, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $284M | 742 | Apr 18, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $263M | 739 | Jan 19, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $233M | 750 | Oct 31, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $217M | 637 | Jul 28, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $223M | 634 | May 4, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 605 | Feb 6, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $202M | 719 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $216M | 656 | Aug 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $270M | 643 | May 2, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $286M | 603 | Feb 9, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $277M | 606 | Nov 5, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $274M | 588 | Aug 6, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $262M | 569 | Apr 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $262M | 533 | Feb 1, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $241M | 562 | Nov 6, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $232M | 569 | Aug 10, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $181M | 632 | Apr 24, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $239M | 514 | Feb 7, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $231M | 510 | Nov 1, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $228M | 535 | Aug 2, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $236M | 516 | May 9, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $208M | 501 | Feb 6, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.